Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Mar 20;67(1):83–92. doi: 10.1007/s00280-010-1287-z

Fig. 1.

Fig. 1

Evaluation of in vitro apoptosis in canine and human OS. Cells were pre-incubated in VPA for 48 h followed by 48 h of combination treatment using 100 ng/mL DOX (Abrams, D17, SAOS2) or 200 ng/mL DOX (SJSA1). Pre-treatment with VPA results in enhanced apoptotic effect compared to DOX alone * P < 0.05